ALVDAL BIOVARME AS

2560 ALVDAL

Finances

Return on Equity

3,91 %

Current Ratio

0,99

Debt-to-Equity Ratio

4,27

Key figures (NOK)	2022	2021	2020	2019
Revenue	5 467 000	5 580 000	5 113 000	3 336 000
Net Income	157 000	629 000	755 000	327 000
Total Assets	25 115 000	17 402 000	17 980 000	14 778 000
Total Equity	4 012 000	3 855 000	3 226 000	2 472 000

Income (NOK)	2022	2021	2020	2019
Revenue	5 467 000	5 580 000	5 113 000	3 336 000
Expenditure	4 797 000	4 423 000	3 728 000	2 541 000
Operating Profit	670 000	1 157 000	1 386 000	794 000
Financial Income	26 000	25 000	20 000	20 000
Financial Costs	496 000	375 000	438 000	395 000
Financial Balance	−470 000	−350 000	−418 000	−375 000
Earnings Before Tax	201 000	807 000	967 000	420 000
Tax	44 000	177 000	213 000	92 000
Net Income	157 000	629 000	755 000	327 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	21 191 000	15 556 000	15 857 000	13 340 000
Total Current Assets	3 924 000	1 846 000	2 123 000	1 438 000
Total Assets	25 115 000	17 402 000	17 980 000	14 778 000
Total Retained Equity	2 158 000	2 001 000	1 372 000	618 000
Total Equity	4 012 000	3 855 000	3 226 000	2 472 000
Total Long-Term Debt	17 140 000	11 371 000	11 775 000	9 530 000
Total Current Debt	3 963 000	2 175 000	2 978 000	2 776 000
Total Equity and Debt	25 115 000	17 402 000	17 980 000	14 778 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	5 467 000	5 580 000	5 113 000	3 313 000
Other Income	0	0	0	23 000
Revenue	5 467 000	5 580 000	5 113 000	3 336 000
Cost of Goods Sold	1 305 000	924 000	1 257 000	594 000
Salary Costs	304 000	828 000	444 000	582 000
Depreciation	1 168 000	1 080 000	887 000	734 000
Impairment	0	0	0	0
Expenditure	4 797 000	4 423 000	3 728 000	2 541 000
Operating Profit	670 000	1 157 000	1 386 000	794 000
Financial Income	26 000	25 000	20 000	20 000
Financial Costs	496 000	375 000	438 000	395 000
Financial Balance	−470 000	−350 000	−418 000	−375 000
Dividends	0	0	0	0
Net Income	157 000	629 000	755 000	327 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	13 397 000	8 870 000	10 035 000	5 118 000
Machinery and Plant Facilities	6 631 000	5 362 000	4 339 000	7 878 000
Fixtures	1 163 000	1 323 000	1 484 000	344 000
Total Tangible Assets	21 191 000	15 556 000	15 857 000	13 340 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	21 191 000	15 556 000	15 857 000	13 340 000
Stock	294 000	305 000	278 000	178 000
Total Investments	8 000	8 000	8 000	8 000
Cash, Bank	1 232 000	404 000	150 000	37 000
Total Current Assets	3 924 000	1 846 000	2 123 000	1 438 000
Total Assets	25 115 000	17 402 000	17 980 000	14 778 000
Total Equity	4 012 000	3 855 000	3 226 000	2 472 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	17 140 000	11 371 000	11 775 000	9 530 000
Creditors	3 048 000	1 265 000	1 771 000	1 457 000
Unpaid Taxes	125 000	281 000	185 000	156 000
Dividends	0	0	0	0
Other Current Debt	789 000	629 000	1 023 000	1 163 000
Total Current Debt	3 963 000	2 175 000	2 978 000	2 776 000
Total Equity and Debt	25 115 000	17 402 000	17 980 000	14 778 000

Financial indicators	2022	2021	2020	2019
Return on Equity	3,91 %	16,32 %	23,4 %	13,23 %
Debt-to-Equity Ratio	4,27	2,95	3,65	3,86
Operating Profit Margin	12,26 %	20,73 %	27,11 %	23,8 %
Current Ratio	0,99	0,85	0,71	0,52
Quick Ratio	1,07	0,99	0,79	0,55
Equity Ratio	0,16	0,22	0,18	0,17
Gross Profit Margin	76,13 %	83,44 %	75,42 %	82,19 %